NCT00995384

Brief Summary

The purpose of this study is to assess the effectiveness of cardiac CT versus TEE in endocarditis patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2009

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2009

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

October 14, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 15, 2009

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2010

Completed
Last Updated

March 28, 2023

Status Verified

March 1, 2012

Enrollment Period

1 year

First QC Date

October 14, 2009

Last Update Submit

March 24, 2023

Conditions

Endocarditis

Outcome Measures

Primary Outcomes (1)

  • Visual Difference in CT versus TEE images in Endocarditis

    Upon CT Scan

Secondary Outcomes (1)

  • Morbidity

    4 weeks & 6 months post CT scan

Study Arms (1)

CT scan

OTHER

CT Scan for endocarditis patients. All patients receive intervention.

Procedure: CT Scan

Interventions

CT ScanPROCEDURE

Cardiac CT with special attention to valves in Endocarditis patients.

CT scan

Eligibility Criteria

Age18 Years - 98 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute endocarditis with positive TEE

You may not qualify if:

  • Renal failure
  • Contrast dye allergy
  • Beta-blocker allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

William Beaumont Hosptial

Royal Oak, Michigan, 48073, United States

Location

MeSH Terms

Conditions

Endocarditis

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Phillip Kadaj, MD

    Corewell Health East

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2009

First Posted

October 15, 2009

Study Start

October 1, 2009

Primary Completion

October 1, 2010

Study Completion

October 1, 2010

Last Updated

March 28, 2023

Record last verified: 2012-03

Locations

US(1)